New Dehli – India’s first vaccine for the prevention of coronavirus infection, COVAXIN’s clinical trials on humans started at AIIMS Hospital in Delhi. In the first phase of testing, the Covaxin would be given to 375 volunteers. This vaccine will be tested on 100 volunteers in the AIIMS Hospital and the trials on the remaining 275 volunteers will be conducted in other centres of the country. This vaccine will be given only to the first 50 volunteers out of 100 volunteers of AIIMS. If the findings of this test are found affirmative, the details of this test will be sent to the data committee of ICMR. According to this test, if everything goes well, this vaccine will be given to other volunteers.
AIIMS on Monday, announced that it will start screening volunteers for phase-1 testing of the indigenous #COVID19 vaccine, Covaxin, , on healthy persons aged 18-55, without co-morbidities https://t.co/Aq2ZBUoxJM
— The Hindu (@the_hindu) July 21, 2020
Hyderabad’s Bharat Biotech jointly with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV) have developed the Covaxin vaccine. The generic name of this vaccine is BVB-152.
Adulteration in milk and dairy products will be dealt with on a priority basis!
Benches, bricks and decorative items to be made from the POP recovered from immersed Lord Ganesha idols!
Bedsheet bearing a ‘Made in Pakistan’ label sold at the Fair near Shri Moraya Gosavi Temple in Chinchwad (Pune)!
Hindu Police Inspector commits suicide due to religious harassment by a Muslim officer at Budaun, UP
Mumbai has become a hub of Bangladeshi Infiltrators; More than 1500 Hideouts of Infiltrators!
‘Devasthan Inam Abolition Draft Act 2026’ put on hold